Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)

Q32 Bio's Long-Term Investments history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2025.

• On a quarterly basis, Long-Term Investments fell 46.53% year-over-year to $2.5 million in Q1 2025; TTM through Mar 2025 was $2.5 million, a 46.53% decrease from a year earlier, with the FY2024 full-year figure at $2.6 million, changed N/A from the prior year.
• Long-Term Investments slipped to $2.5 million in Q1 2025 per QTTB's latest filing, from $2.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $30.6 million in Q1 2022 and bottomed at $2.5 million in Q1 2025.
• The 4-year median for Long-Term Investments is $15.6 million (2023), against an average of $15.2 million.
• Across the five-year window, Long-Term Investments slipped 24.93% in 2023 and plunged 81.37% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $25.8 million in 2022, then plunged by 45.93% to $14.0 million in 2023, then plunged by 81.37% to $2.6 million in 2024, then retreated by 2.85% to $2.5 million in 2025.
• Per Business Quant, the three latest QTTB Long-Term Investments figures stand at $2.5 million (Q1 2025), $2.6 million (Q4 2024), and $2.6 million (Q3 2024).